Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000090·JANUS HENDERSON GROUP PLC
Schedule 13G ownership disclosure
Ligand Pharmaceuticals Inc
Common Stock · CUSIP: 53220K504
Event date: 2024-12-31
- Filing-level shares
- 1,015,023
- Percent of class
- 5.4%
- JANUS HENDERSON GROUP PLC
Shares: 1,015,023 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000090
- Form type
- SCHEDULE 13G/A
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership